Previous 10 | Next 10 |
22nd Century Group (NASDAQ: XXII) , a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and improving health and wellness through modern plant science, today announced its appointment of John J. Miller to direct the growth and achieve th...
Highly Regarded for His Extensive Sales and Marketing Experience in the Tobacco Industry Expands and Further Strengthens the Company’s Team of Tobacco Industry Experts BUFFALO, N.Y., May 23, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII ), a le...
Complete Hemp/Cannabis Solution from Receptor Science and Plant Genetics to Final Ingredients and CDMO Consistent, Reliable, High-Quality Cannabinoids and Cannabinoid Infused Products for Consumers Acquisition Immediately Accretive; Will Double 22nd Century Revenue BUFFALO...
Shares of 22nd Century (NASDAQ:XXII) rose 9.6% to $1.72 in Friday morning trade, after the biotech firm acquired privately held hemp/cannabis company GVB Biopharma. XXII said the deal consideration consisted of the assumption of about $4.5M of debt, GVB's closing costs and the issuance to GVB...
Provides Transformational Platform to Rapidly Grow Hemp/Cannabis Franchise Transaction Immediately Accretive and Will Double Company’s Total Revenue Adds Significant Commercial Scale to Existing Hemp/Cannabis Franchise GVB Biopharma has Achieved Strong Growth and Lead...
22nd Century Group reported $9 million in revenues for Q1-2022, up 33% YoY. The company has released its VLN cigarettes in America (Chicago) and South Korea. The company is bringing in revenues from its cannabis intellectual properties and sale of distillate. The companyȁ...
Image source: The Motley Fool. 22nd Century Group (NASDAQ: XXII) Q1 2022 Earnings Call May 05, 2022 , 10:00 a.m. ET Operator Continue reading For further details see: 22nd Century Group (XXII) Q1 2022 Earnings Call Transcript
22nd Century Group, Inc. (XXII) Q1 2022 Earnings Conference Call May 05, 2022 10:00 AM ET Company Participants Mei Kuo – Director of Communications and Investor Relations Jim Mish – Chief Executive Officer Mike Zercher – President and Chief Operating Officer Rich Fitzgera...
The following slide deck was published by 22nd Century Group, Inc. in conjunction with their 2022 Q1 earnings call. For further details see: 22nd Century Group, Inc. 2022 Q1 - Results - Earnings Call Presentation
22nd Century press release (NASDAQ:XXII): Q1 GAAP EPS of -$0.05 beats by $0.02. Revenue of $9.05M (+32.9% Y/Y) beats by $0.78M. James A. Mish, chief executive officer of 22nd Century Group, stated: “We are off to an exciting start with our VLN® reduced nicotine content cigare...
News, Short Squeeze, Breakout and More Instantly...
22nd Century Group Inc Company Name:
XXII Stock Symbol:
NYSE Market:
22nd Century Group Inc Website:
Patented, Fully Water Dispersing, Biodegradable Solution for World's Most Littered Item Mocksville, North Carolina--(Newsfile Corp. - July 10, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction and contract manufacturing, today announce...
Mocksville, North Carolina--(Newsfile Corp. - July 9, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction and contract manufacturing, today announced a new agreement for full-scale commercial rollout of its VLN® reduced nicotine cont...
Mocksville, North Carolina--(Newsfile Corp. - June 25, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction and contract manufacturing, today announced a $1.5 million reduction in its secured debt via a paydown of the GVB secured promissor...